Deborah K. Ross bought NeoGenomics Inc (NASDAQ: NEO)
Deborah K. Ross (D-NC), a U.S. Representative, has disclosed 1 trade in NeoGenomics Inc (NEO) since 2021, a single purchase, worth an estimated $33K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: Deborah K. Ross bought $15,001 - $50,000 of NeoGenomics Inc (NASDAQ: NEO) on December 30, 2021. Since that trade, NEO is down -53.50% against the S&P 500 up +65.12%, an outperformance of -118.62%.
Data updated
Deborah K. Ross's NEO trades vs the price
NEO is down -53.50% since Deborah K. Ross bought on December 30, 2021, versus +65.12% for the S&P 500.
Performance since this trade
All Deborah K. Ross NEO trades
Deborah K. Ross & NEO trading FAQ
Is it legal for Deborah K. Ross to trade NeoGenomics Inc (NEO) stock?
Yes. Members of Congress are allowed to trade individual stocks, including NeoGenomics Inc (NEO), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Deborah K. Ross buy NEO?
Deborah K. Ross disclosed a purchase of $15,001 - $50,000 of NeoGenomics Inc (NEO) on December 30, 2021, according to public STOCK Act filings.
How has NEO performed since Deborah K. Ross's trade?
Since Deborah K. Ross bought NEO on December 30, 2021, the stock is down -53.50%, versus +65.12% for the S&P 500 over the same period, an outperformance of -118.62%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional NEO trades?
Quantellect tracks every disclosed congressional trade in NeoGenomics Inc (NEO) on the NeoGenomics Inc congressional trading page, which aggregates filings across all members of Congress.
Deborah K. Ross's NEO tradesAll congressional filings for NeoGenomics IncDeborah K. Ross's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.